New Chinese Funding Source open for business

Dynasty Biotechnology is pleased to announce commencement of a major partnership with Cambridge-based Nuformix in a long term, multi-product agreement.

The Nuformix biobetter products fit perfectly within the Dynasty portfolio of China-relevant assets to be developed and commercialised in China and rolled out to non-China markets. “We are delighted to be working with Nuformix and to come to agreement on the first set of assets,” commented Dynasty CEO Dr Simon ...

Continue Reading →